Humanized CAR-T Therapy for Treatment of B Cell Malignancy

Clinical trial NCT02782351 · UNKNOWN

Trial details

NCT number: NCT02782351
Sponsor: Kai Lin Xu; Jun Nian Zheng
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2016-05-01
Primary completion: 2018-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.